OHRP COVID-19 Guidance
The Office for Human Research Protections (OHRP) has provided guidance on COVID-19. Read More >>
Updated FDA Guidance for COVID19
The FDA has issued the following guidance on the conduct of clinical trials of medical products during the COVID-19 pandemic.
Notification to Clients: COVID-19 Policy Exception Statement
Salus IRB issues policy exception statement for reviewing study modifications due to COVID-19.